## BACKGROUND. The objective of this study was to evaluate the indications for percutaneous ethanol injection (PEI) performed in a single session under general anesthesia for treating patients with cirrhosis and large (tumors ΟΎ 5 cm) hepatocellular carcinoma (HCC), and relevant survival curves. #
Long-term survival in a patient with hepatocellular carcinoma with resection of a metastatic lymph node after percutaneous ethanol injection therapy
β Scribed by Shinji Togo; Tetsuya Takahashi; Kuniya Tanaka; Itaru Endo; Hitoshi Sekido; Hiroshi Shimada
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 433 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1341-9625
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: The objective of this study was to identify clinical, biochemical, ultrasound, and/or pathologic parameters capable of predicting survival in a cohort of patients with well compensated cirrhosis and small hepatocellular carcinoma (hcc) who were treated with percutaneous ethanol injec
## Background: The long term efficacy of combination therapy with transcatheter arterial embolization (tae) followed by percutaneous ethanol injection (pei) was studied in patients with large primary hepatocellular carcinoma (hcc) tumors and cirrhosis. ## Methods: The series included 83 patients
Hepatocellular carcinoma (HCC) is one of the most severe sequelae of chronic liver disease. The only potentially curative therapeutic options are surgical resection and orthotopic liver transplantation. In most HCC patients, however, at clinical presentation the tumors are unresectable because of mu
## Abstract ## BACKGROUND Advances in the diagnosis and surgical treatment of hepatocellular carcinoma (HCC) have improved the prognosis for patients with HCC who undergo liver resection. The objective of this study was to evaluate prognostic predictors for patients with HCC who underwent liver re